Jnk3 has been shown to stabilize p27 and led to growth arrest in C6 glioma cells, and so, following this precept, we confirmed that Jnk3‐shRNA down‐regulates p27, enhancing expression of Cdk2 in CMs for proliferation. The gene discussed is CDK2; the disease is central nervous system cancer.